Top 20 of Tumor Virus Infections

Article title # Publications/# Citations

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

1983: CAxler-Blin; FBarré-Sinoussi; SChamaret; JCChermann; CDauguet; JGruest; LMontagnier; MTNugeyre; ... FRey; CRouzioux; WRozenbaum; FVézinet-Brun;


Papillomaviruses and cancer: from basic studies to clinical application.

2002: Hzur Hausen;


Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

1995: FXBosch; AMJansen; RKurman; MMManos; VMoreno; NMunoz; JPeto; MHSchiffman; KVShah; MSherman;


MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

1979: PCDoherty; RMZinkernagel;


The global health burden of infection-associated cancers in the year 2002.

2006: DMParkin;


Clonal integration of a polyomavirus in human Merkel cell carcinoma.

2008: YChang; HFeng; PSMoore; MShuda;


Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

2000: RBCapone; RWDaniel; MLGillison; WMKoch; KVShah; DSidransky; MSpafford; DESymer; ... MViglione; WHWestra; LWu; MLZahurak;


The causal relation between human papillomavirus and cervical cancer.

2002: FXBosch; ALőrincz; CJMeijer; NMunoz; KVShah;


A review of human carcinogens--Part B: biological agents.

2009: WHO International Agency for Research on Cancer Monograph Working Group; RBaan; LBenbrahim-Tallaa; VBouvard; VCogliano; FEl Ghissassi; CFreeman; LGalichet; ... YGrosse; NGuha; BSecretan; KStraif;


Natural history of cervicovaginal papillomavirus infection in young women.

1998: LBeardsley; RBierman; RDBurk; CJChang; GYHo;


Papillomavirus infections--a major cause of human cancers.

1996: Hzur Hausen;


Improved amplification of genital human papillomaviruses.

2000: TQAlessi; RJApple; FCoutlée; PEGravitt; AHildesheim; CLPeyton; MHSchiffman; DRScott; CMWheeler;


Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

2003: JGJones; PLi; EYLin; WJMuller; JWPollard; KDWhitney; LZhu;


Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

2005: RPAndrade; KAAult; EBarr; DRBrown; RLCosta; MTEsser; AFerenczy; ARGiuliano; ... DMHarper; KUJansen; LAKoutsky; RJKurman; MLehtinen; LLupinacci; CMalm; SEOlsson; CAPetta; RRailkar; BMRonnett; AJSaah; HLSings; FESkjeldestad; MSteinwall; MHStoler; FJTaddeo; GMTamms; LLVilla; CMWheeler; JYu;


A controlled trial of a human papillomavirus type 16 vaccine.

2002: Proof of Principle Study Investigators; FBAlvarez; KAAult; EBarr; DRBrown; LMChiacchierini; KUJansen; LAKoutsky; CMWheeler;


Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.

1998: HJDelecluse; WHammerschmidt; THilsendegen; DPich; RZeidler;


The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

1995: AMde Roda Husman; CJMeijer; PJSnijders; AJvan den Brule; JMWalboomers;


Characterization of a newly derived human sarcoma cell line (HT-1080).

1974: PArnstein; MBGardner; WANelson-Rees; SRasheed; EMTóth;


Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.

2009: RKBagni; JDas Gupta; MDean; BGold; KSHagen; VCLombardi; JAMikovits; DLPeterson; ... CPetrow-Sadowski; MAPfost; FWRuscetti; SKRuscetti; RHSilverman;


Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

2003: GMClifford; SFranceschi; NMunoz; MPlummer; JSSmith;